Barbara Klencke, Director at TScan Therapeutics, Inc. (TCRX), bought 5,000 shares at $5.08 ($25K) on 2023-12-14, disclosed to the SEC on 2023-12-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| SRRA | BUY | 2020-08-18 | $113K | — | Filing → |
| SRRA | BUY | 2019-08-26 | $101K | — | Filing → |